Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 35.85 USD -0.55% Market Closed
Market Cap: 313.7m USD

Intrinsic Value

The intrinsic value of one TNXP stock under the Base Case scenario is 109.21 USD. Compared to the current market price of 35.85 USD, Tonix Pharmaceuticals Holding Corp is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TNXP Intrinsic Value
109.21 USD
Undervaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tonix Pharmaceuticals Holding Corp

What is Valuation History?
Compare TNXP to

Fundamental Analysis

Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
US
Biotechnology
Market Cap
313.7m USD
IPO
Mar 29, 2010
US
Biotechnology
Market Cap
313.7m USD
IPO
Mar 29, 2010
Price
$false
EPS
$false
Tonix Pharmaceuticals Holding Corp
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TNXP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Tonix Pharmaceuticals Holding Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tonix Pharmaceuticals Holding Corp

Current Assets 143.5m
Cash & Short-Term Investments 125.3m
Receivables 4.3m
Other Current Assets 13.9m
Non-Current Assets 43.8m
PP&E 42.8m
Intangibles 120k
Other Non-Current Assets 931k
Efficiency

Free Cash Flow Analysis
Tonix Pharmaceuticals Holding Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tonix Pharmaceuticals Holding Corp

Revenue
9.8m USD
Cost of Revenue
-7m USD
Gross Profit
2.9m USD
Operating Expenses
-87.4m USD
Operating Income
-84.5m USD
Other Expenses
3.1m USD
Net Income
-81.4m USD
Fundamental Scores

TNXP Profitability Score
Profitability Due Diligence

Tonix Pharmaceuticals Holding Corp's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
15/100
Profitability
Score

Tonix Pharmaceuticals Holding Corp's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

TNXP Solvency Score
Solvency Due Diligence

Tonix Pharmaceuticals Holding Corp's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
59/100
Solvency
Score

Tonix Pharmaceuticals Holding Corp's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp

Wall Street analysts forecast TNXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNXP is 62.9 USD with a low forecast of 50.5 USD and a high forecast of 73.5 USD.

Lowest
Price Target
50.5 USD
41% Upside
Average
Price Target
62.9 USD
75% Upside
Highest
Price Target
73.5 USD
105% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Tonix Pharmaceuticals Holding Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for TNXP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TNXP Insider Trading
Buy and sell transactions by insiders

TNXP News

Other Videos
What is the Intrinsic Value of one TNXP stock?

The intrinsic value of one TNXP stock under the Base Case scenario is 109.21 USD.

Is TNXP stock undervalued or overvalued?

Compared to the current market price of 35.85 USD, Tonix Pharmaceuticals Holding Corp is Undervalued by 67%.

Back to Top